We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NPTN
2301
DELISTED
NEOPHOTONICS CORP
NPTN
| $769K | ﹤0.01% |
64,321
-3,256
| -5% | -$36.9K |
|
2302
Uranium Energy
UEC
$5.57B
| $768K | ﹤0.01% |
268,419
-10,840
| -4% | -$23.7K |
|
2303
Inseego
INSG
$90.5M
| $767K | ﹤0.01% |
7,669
-1,081
| -12% | -$157K |
|
|
WIFI
2304
DELISTED
Boingo Wireless, Inc.
WIFI
| $767K | ﹤0.01% |
54,496
-3,490
| -6% | -$45.5K |
|
2305
Driven Brands
DRVN
$2.2B
| $766K | ﹤0.01% |
+30,144
| New | +$855K |
|
2306
Bladex Inc
BLX
$2.14B
| $764K | ﹤0.01% |
50,479
-2,395
| -5% | -$37.7K |
|
|
AVID
2307
DELISTED
Avid Technology Inc
AVID
| $763K | ﹤0.01% |
36,140
-2,600
| -7% | -$50.9K |
|
|
GHL
2308
DELISTED
Greenhill & Co., Inc.
GHL
| $759K | ﹤0.01% |
46,052
-202
| -0.4% | -$2.98K |
|
2309
Anavex Life Sciences
AVXL
$310M
| $756K | ﹤0.01% |
50,593
+5,041
| +11% | +$55.1K |
|
2310
Ranpak Holdings
PACK
$473M
| $755K | ﹤0.01% |
37,642
-2,380
| -6% | -$44.3K |
|
2311
York Water
YORW
$514M
| $755K | ﹤0.01% |
15,426
-1,010
| -6% | -$46.1K |
|
2312
Nurix Therapeutics
NRIX
$2.65B
| $753K | ﹤0.01% |
24,215
+12,592
| +108% | +$476K |
|
2313
Republic Bancorp
RBCAA
$1.95B
| $747K | ﹤0.01% |
16,859
-500
| -3% | -$20.7K |
|
|
FFG
2314
DELISTED
FBL Financial Group
FFG
| $746K | ﹤0.01% |
13,338
-1,865
| -12% | -$105K |
|
|
FRTA
2315
DELISTED
Forterra, Inc
FRTA
| $743K | ﹤0.01% |
31,940
-117
| -0.4% | -$2.52K |
|
|
PAND
2316
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
| $743K | ﹤0.01% |
+12,368
| New | +$448K |
|
2317
AXT Inc
AXTI
$5.8B
| $742K | ﹤0.01% |
63,642
-2,440
| -4% | -$29.3K |
|
2318
Arrow Financial
AROW
$652M
| $741K | ﹤0.01% |
24,324
-852
| -3% | -$25.1K |
|
2319
Bar Harbor Bankshares
BHB
$666M
| $740K | ﹤0.01% |
25,153
-840
| -3% | -$21.9K |
|
2320
Byline Bancorp
BY
$1.76B
| $737K | ﹤0.01% |
34,833
-1,650
| -5% | -$30.9K |
|
2321
CRA International
CRAI
$1.06B
| $733K | ﹤0.01% |
9,827
-680
| -6% | -$41.3K |
|
2322
Merchants Bancorp
MBIN
$2.49B
| $733K | ﹤0.01% |
26,210
-375
| -1% | -$8.7K |
|
2323
Certara
CERT
$1.25B
| $731K | ﹤0.01% |
+26,766
| New | +$890K |
|
2324
Viking Therapeutics
VKTX
$4B
| $726K | ﹤0.01% |
114,751
-5,510
| -5% | -$38.8K |
|
2325
Gossamer Bio
GOSS
$87M
| $724K | ﹤0.01% |
78,268
-4,040
| -5% | -$40.7K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.